InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-23.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Levy Howard, Directeur Médical. Insider active across 1 company, notably Catalyst Biosciences, INC.. Aggregated, 2 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €4k. Activity tracked since 9 August 2021. The latest transaction was disclosed on 9 August 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
639 shares@ US$3.620.0004% mcap50.0% of flowCommon StockSEC:0001209191-21-050758:0
Canonical exit: 7 Nov 2021 (T+90)
639 shares@ US$3.6250.0% of flowCommon StockSEC:0001209191-21-050758
Canonical exit: 7 Nov 2021 (T+90)
2 of 2 declarations
About Levy Howard
Howard Levy is the Chief Medical Officer of CATALYST BIOSCIENCES, INC. He is responsible for medical leadership and product development strategy. His expertise is essential in ensuring the quality of the company's products and services.
